Literature DB >> 31163136

Use of High-Resolution Optical Coherence Tomography in the Surgical Management of Ocular Surface Squamous Neoplasia: A Pilot Study.

Carol L Karp1, Carolina Mercado2, Nandini Venkateswaran2, Marco Ruggeri2, Anat Galor3, Armando Garcia2, Kavitha R Sivaraman2, Maria Paula Fernandez2, Antonio Bermudez2, Sander R Dubovy4.   

Abstract

PURPOSE: To evaluate whether high-resolution optical coherence tomography (HR-OCT) can detect histologic tumor margins of ocular surface squamous neoplasia (OSSN).
METHODS: Eight eyes of 8 patients with OSSN undergoing excision were studied prospectively. Immediately before surgery, the tumor was imaged using commercially available HR-OCT to identify the conjunctival margins of the neoplastic lesion. The tumor borders of the lesion determined by HR-OCT were mapped in relation to an anatomic reference point and transferred intraoperatively. The tumor was excised with 4-mm margins from the visible edge of the lesion with a "no-touch" technique. The specimens were sent for pathologic analysis and the histologic tumor margin was compared to the HR-OCT predicted tumor border.
RESULTS: Mean age of the 8 patients was 67 ± 9.9 years. Seven were male, 7 were white, and, ethnically, 3 were Hispanic. All 8 tumors were bulbar and in the exposure zone. Seven tumors were limbal. Corneal extension was present in 5. Mean tumor area was 17.5 ± 11.1 mm2. Clinically, 2 of the tumors were leukoplakic, 1 papillomatous, and 3 gelatinous. A conjunctival tumor margin identified with the HR-OCT coincided with the pathologically confirmed margin mark in all eyes.
CONCLUSIONS: HR-OCT has the potential to predict histologic tumor margins in OSSN. Optical identification of tumor margins could potentially decrease the incidence of residual positive margins and minimize healthy tissue removal. Advances in HR-OCT technology and integration into a microscope for "real-time" imaging are needed to further improve this technique. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31163136      PMCID: PMC6885111          DOI: 10.1016/j.ajo.2019.05.017

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  50 in total

Review 1.  Ocular surface squamous neoplasia.

Authors:  Christine A Kiire; Sathish Srinivasan; Carol L Karp
Journal:  Int Ophthalmol Clin       Date:  2010

Review 2.  Optical coherence tomography of the anterior segment.

Authors:  Trefford Simpson; Desmond Fonn
Journal:  Ocul Surf       Date:  2008-07       Impact factor: 5.033

3.  Epidemiology of squamous cell conjunctival cancer.

Authors:  E C Sun; T R Fears; J J Goedert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-02       Impact factor: 4.254

Review 4.  Ultra-high resolution optical coherence tomography for imaging the anterior segment of the eye.

Authors:  Jianhua Wang; Mohamed Abou Shousha; Victor L Perez; Carol L Karp; Sonia H Yoo; Meixiao Shen; Lele Cui; Volkan Hurmeric; Chixin Du; Dexi Zhu; Qi Chen; Ming Li
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011-07

Review 5.  High-Resolution Optical Coherence Tomography as an Adjunctive Tool in the Diagnosis of Corneal and Conjunctival Pathology.

Authors:  Afshan A Nanji; Fouad E Sayyad; Anat Galor; Sander Dubovy; Carol L Karp
Journal:  Ocul Surf       Date:  2015-04-06       Impact factor: 5.033

6.  Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases.

Authors:  Yacoub A Yousef; Paul T Finger
Journal:  Ophthalmology       Date:  2011-12-20       Impact factor: 12.079

7.  Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia.

Authors:  G Tabin; S Levin; G Snibson; M Loughnan; H Taylor
Journal:  Ophthalmology       Date:  1997-03       Impact factor: 12.079

8.  Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors.

Authors:  Carol L Shields; Hakan Demirci; Ekaterina Karatza; Jerry A Shields
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

Review 9.  Anterior Segment Imaging in Ocular Surface Squamous Neoplasia.

Authors:  Sally S Ong; Gargi K Vora; Preeya K Gupta
Journal:  J Ophthalmol       Date:  2016-10-05       Impact factor: 1.909

10.  Quantitative Evaluation of Microdistortions in Bowman's Layer and Corneal Deformation after Small Incision Lenticule Extraction.

Authors:  Rushad Shroff; Mathew Francis; Natasha Pahuja; Leio Veeboy; Rohit Shetty; Abhijit Sinha Roy
Journal:  Transl Vis Sci Technol       Date:  2016-10-17       Impact factor: 3.283

View more
  5 in total

1.  Update on imaging modalities for ocular surface pathologies.

Authors:  Osmel P Alvarez; Anat Galor; Ghada AlBayyat; Carol L Karp
Journal:  Curr Ophthalmol Rep       Date:  2021-05-18

Review 2.  The use of high resolution optical coherence tomography (HR-OCT) in the diagnosis of ocular surface masqueraders.

Authors:  Despoina Theotoka; Sarah Wall; Anat Galor; Wathanee Sripawadkul; Rayan Abou Khzam; Vincent Tang; Dubovy L Sander; Carol L Karp
Journal:  Ocul Surf       Date:  2022-02-26       Impact factor: 6.268

3.  Clinical and Optical Coherence Tomography Comparison Between Ocular Surface Squamous Neoplasia and Squamous Metaplasia.

Authors:  Shanlee M Stevens; Daniela P Reyes-Capo; Umangi Patel; Anjalee Choudhary; Rayan Abou Khzam; Vincent Tang; Anat Galor; Carol L Karp; Sander Dubovy
Journal:  Cornea       Date:  2022-04-09       Impact factor: 3.152

Review 4.  Ocular surface squamous neoplasia: management and outcomes.

Authors:  Roland Hӧllhumer; Susan Williams; Pamela Michelow
Journal:  Eye (Lond)       Date:  2021-02-09       Impact factor: 4.456

5.  Ocular surface squamous neoplasia in Northern Thailand: a 16-year review.

Authors:  Napaporn Tananuvat; Muanploy Niparugs; Damrong Wiwatwongwana; Nirush Lertprasertsuk; Pongsak Mahanupap
Journal:  BMC Ophthalmol       Date:  2022-03-12       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.